hydrocortisone succinate 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definition	Drug id	CAS RN
corticosteroids, except prednisolone derivatives	4456	125-04-2

Description:

Molecule	Description
Molfile Inchi Smiles Synonyms: hydrocortisone sodium succinate hydrocortisone succinate hydrocortisone hemisuccinate	Molecular weight: 462.54 Formula: C25H34O8 CLOGP: 2.19 LIPINSKI: 0 HAC: 8 HDO: 3 TPSA: 138.20 ALOGS: -3.85 ROTB: 7 Status: OFP Legend: OFP - off patent OFM - off market ONP - on patent

Molecule

Description

Molfile Inchi Smiles

Synonyms:

hydrocortisone sodium succinate
hydrocortisone succinate
hydrocortisone hemisuccinate

Molecular weight: 462.54
Formula: C25H34O8
CLOGP: 2.19
LIPINSKI: 0
HAC: 8
HDO: 3
TPSA: 138.20
ALOGS: -3.85
ROTB: 7

Status: OFP

Legend:
OFP - off patent
OFM - off market
ONP - on patent

Drug dosage:

None

ADMET properties:

Property	Value	Reference
S (Water solubility)	0.23 mg/mL	Bocci G, Oprea TI, Benet LZ

Approvals:

Date	Agency	Company	Orphan
April 27, 1955	FDA	PHARMACIA AND UPJOHN

FDA Adverse Event Reporting System (Female)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Infusion related reaction	253.95	13.56	351	20028	245170	63223473
Flushing	85.89	13.56	113	20266	74974	63393669
Urticaria	65.25	13.56	156	20223	165646	63302997
Toxicity to various agents	60.68	13.56	5	20374	247245	63221398
Intentional product use issue	44.65	13.56	115	20264	127777	63340866
Drug ineffective	41.48	13.56	184	20195	1044581	62424062
Blood pressure fluctuation	38.63	13.56	60	20319	46257	63422386
Off label use	37.54	13.56	355	20024	674107	62794536
Drug interaction	36.41	13.56	14	20365	229117	63239526
Febrile neutropenia	35.80	13.56	101	20278	118348	63350295
Swollen joint count increased	34.78	13.56	50	20329	36004	63432639
Chest discomfort	34.44	13.56	95	20284	109874	63358769
Disseminated intravascular coagulation	33.96	13.56	36	20343	19015	63449628
Rheumatic fever	32.05	13.56	53	20326	43058	63425585
Blood pressure decreased	30.91	13.56	66	20313	64956	63403687
Sciatica	30.79	13.56	46	20333	34278	63434365
Deep vein thrombosis postoperative	30.70	13.56	27	20352	11342	63457301
Pyrexia	26.77	13.56	249	20130	470229	62998414
Oxygen saturation decreased	24.31	13.56	73	20306	88512	63380131
External ear cellulitis	23.34	13.56	7	20372	283	63468360
Anaphylactic shock	23.12	13.56	33	20346	23600	63445043
Autoimmune disorder	23.03	13.56	28	20351	17149	63451494
Adrenocortical insufficiency acute	22.60	13.56	11	20368	1687	63466956
Pruritus	21.90	13.56	194	20185	361259	63107384
Throat tightness	21.82	13.56	33	20346	24854	63443789
Inappropriate schedule of product administration	21.64	13.56	78	20301	103887	63364756
Cytomegalovirus infection	21.60	13.56	30	20349	20922	63447721
Poor venous access	21.30	13.56	25	20354	14760	63453883
Endometritis decidual	20.86	13.56	4	20375	21	63468622
Type 2 diabetes mellitus	20.81	13.56	56	20323	63812	63404831
Road traffic accident	20.75	13.56	40	20339	36592	63432051
Colitis ulcerative	20.64	13.56	33	20346	26058	63442585
Helicobacter infection	20.51	13.56	71	20308	92714	63375929
Injection site pain	20.49	13.56	8	20371	129792	63338851
Shock	20.41	13.56	31	20348	23432	63445211
Septic shock	20.29	13.56	57	20322	66572	63402071
Vascular rupture	19.63	13.56	10	20369	1690	63466953
Duodenal ulcer perforation	19.50	13.56	67	20312	87142	63381501
Feeling hot	19.36	13.56	47	20332	50307	63418336
Death	19.29	13.56	59	20320	374322	63094321
Erythema	19.27	13.56	109	20270	175642	63293001
Abdominal pain	19.07	13.56	160	20219	293296	63175347
Throat irritation	18.80	13.56	39	20340	37608	63431035
Genital rash	18.77	13.56	7	20372	557	63468086
Cytomegalovirus viraemia	18.51	13.56	15	20364	5634	63463009
Bronchospasm	18.20	13.56	25	20354	17255	63451388
Product use issue	18.10	13.56	127	20252	220393	63248250
Lupus vulgaris	17.73	13.56	15	20364	5979	63462664
Intestinal resection	17.28	13.56	11	20368	2837	63465806
Wheezing	16.83	13.56	68	20311	95527	63373116
Tracheal inflammation	16.81	13.56	4	20375	65	63468578
Apocrine miliaria	16.74	13.56	3	20376	10	63468633
Fall	16.74	13.56	67	20312	392267	63076376
Facet joint syndrome	16.62	13.56	20	20359	12118	63456525
Dislocation of vertebra	16.61	13.56	17	20362	8618	63460025
Epiglottitis	16.57	13.56	6	20373	439	63468204
Heart rate increased	16.56	13.56	67	20312	94171	63374472
Blood pressure increased	16.14	13.56	98	20281	161964	63306679
Lower limb fracture	15.66	13.56	28	20351	24193	63444450
Rheumatoid arthritis	15.32	13.56	37	20342	253782	63214861
Oropharyngeal discomfort	15.23	13.56	13	20366	5247	63463396
Hypoaesthesia	15.01	13.56	99	20280	168294	63300349
Oedema	14.53	13.56	66	20313	97556	63371087
Liver disorder	14.50	13.56	44	20335	53643	63415000
Pharyngitis	13.95	13.56	24	20355	20119	63448524
Crohn's disease	13.93	13.56	12	20367	4901	63463742
X-ray abnormal	13.88	13.56	15	20364	8095	63460548
Hypofibrinogenaemia	13.85	13.56	7	20372	1163	63467480
Gastroenteritis	13.81	13.56	28	20351	26562	63442081
Psoriatic arthropathy	13.71	13.56	62	20317	91458	63377185
Limb mass	13.70	13.56	10	20369	3222	63465421

FDA Adverse Event Reporting System (Male)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Infusion related reaction	308.22	15.12	203	11661	52854	34892213
Nipple swelling	78.84	15.12	19	11845	308	34944759
Nipple pain	63.16	15.12	20	11844	917	34944150
Disseminated intravascular coagulation	56.85	15.12	52	11812	21764	34923303
Pyrexia	54.45	15.12	240	11624	332773	34612294
Flushing	52.88	15.12	60	11804	32360	34912707
Off label use	47.82	15.12	273	11591	419251	34525816
Febrile neutropenia	41.54	15.12	121	11743	136728	34808339
Platelet count decreased	35.50	15.12	105	11759	119612	34825455
Urticaria	32.61	15.12	68	11796	62309	34882758
Anaphylactic reaction	32.43	15.12	47	11817	32254	34912813
Blood iron decreased	32.37	15.12	21	11843	5292	34939775
Frequent bowel movements	32.37	15.12	30	11834	12757	34932310
Chills	30.92	15.12	78	11786	80965	34864102
Product use issue	30.84	15.12	67	11797	63149	34881918
Toxicity to various agents	30.45	15.12	15	11849	200347	34744720
Blood pressure decreased	30.32	15.12	59	11805	51456	34893611
Blood pressure fluctuation	30.24	15.12	40	11824	25209	34919858
Cytomegalovirus infection	29.16	15.12	40	11824	26095	34918972
Neutrophil count decreased	27.05	15.12	56	11808	51048	34894019
Anaphylactic shock	25.13	15.12	29	11835	15912	34929155
Posthaemorrhagic hydrocephalus	23.71	15.12	6	11858	120	34944947
Therapeutic product effect prolonged	23.68	15.12	7	11857	254	34944813
Acute graft versus host disease in skin	23.28	15.12	17	11847	5184	34939883
Large intestine polyp	22.85	15.12	20	11844	7894	34937173
Drug interaction	22.67	15.12	26	11838	225920	34719147
Death	22.02	15.12	66	11798	397983	34547084
Heart rate irregular	22.02	15.12	27	11837	15780	34929287
Antithrombin III decreased	21.98	15.12	7	11857	327	34944740
Septic shock	21.25	15.12	63	11801	71771	34873296
Pallor	21.22	15.12	34	11830	25446	34919621
Erythema	20.93	15.12	72	11792	88708	34856359
Epstein-Barr virus associated lymphoproliferative disorder	20.51	15.12	11	11853	1953	34943114
Cytomegalovirus test positive	20.40	15.12	14	11850	3872	34941195
Polyp	20.38	15.12	14	11850	3878	34941189
Chest discomfort	20.28	15.12	52	11812	54478	34890589
Cytomegalovirus viraemia	19.91	15.12	18	11846	7412	34937655
Pituitary tumour recurrent	19.76	15.12	5	11859	100	34944967
Blood pressure increased	19.51	15.12	70	11794	88032	34857035
Engraft failure	19.39	15.12	7	11857	480	34944587
Overdose	18.76	15.12	4	11860	91055	34854012
Oxygen saturation decreased	18.66	15.12	50	11814	53768	34891299
Vein rupture	18.31	15.12	8	11856	906	34944161
Toxic epidermal necrolysis	18.19	15.12	29	11835	21617	34923450
White blood cell count decreased	17.97	15.12	72	11792	95373	34849694
Chronic graft versus host disease	16.70	15.12	13	11851	4360	34940707
Cerebellar tumour	16.59	15.12	4	11860	65	34945002
Intentional product use issue	16.32	15.12	51	11813	59765	34885302
Hepatic function abnormal	16.17	15.12	42	11822	44321	34900746
Traumatic shock	15.95	15.12	3	11861	13	34945054

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Infusion related reaction	284.04	12.79	371	26933	229866	79487218
Off label use	98.63	12.79	587	26717	906628	78810456
Toxicity to various agents	89.16	12.79	18	27286	421522	79295562
Nipple swelling	79.02	12.79	19	27285	302	79716782
Urticaria	75.69	12.79	184	27120	185017	79532067
Blood pressure fluctuation	68.64	12.79	99	27205	67046	79650038
Intentional product use issue	65.23	12.79	154	27150	151958	79565126
Flushing	59.88	12.79	108	27196	88160	79628924
Nipple pain	59.09	12.79	19	27285	907	79716177
Disseminated intravascular coagulation	59.05	12.79	67	27237	35775	79681309
Febrile neutropenia	58.50	12.79	193	27111	230806	79486278
Product use issue	58.31	12.79	181	27123	209641	79507443
Pyrexia	56.33	12.79	411	26893	678298	79038786
Drug interaction	52.91	12.79	39	27265	415144	79301940
Blood pressure decreased	45.14	12.79	103	27201	99363	79617721
Platelet count decreased	43.46	12.79	156	27148	194508	79522576
Frequent bowel movements	43.29	12.79	52	27252	29487	79687597
Cytomegalovirus viraemia	42.07	12.79	35	27269	12786	79704298
Swollen joint count increased	41.45	12.79	45	27259	22882	79694202
Death	39.90	12.79	84	27220	566430	79150654
Inappropriate schedule of product administration	39.65	12.79	118	27186	133510	79583574
Rheumatic fever	38.22	12.79	48	27256	28477	79688607
Cytomegalovirus infection	38.03	12.79	59	27245	42585	79674499
Fall	36.29	12.79	70	27234	487559	79229525
Anaphylactic reaction	32.89	12.79	82	27222	83661	79633423
Septic shock	32.30	12.79	104	27200	122697	79594387
Bronchospasm	31.99	12.79	41	27263	24818	79692266
Overdose	31.21	12.79	12	27292	184194	79532890
Anaphylactic shock	30.98	12.79	49	27255	35947	79681137
Poor venous access	30.01	12.79	34	27270	18115	79698969
Chest discomfort	29.41	12.79	109	27195	137935	79579149
Neutrophil count decreased	28.84	12.79	84	27220	93875	79623209
Deep vein thrombosis postoperative	28.52	12.79	26	27278	10726	79706358
Sciatica	28.28	12.79	45	27259	33177	79683907
Shock	27.89	12.79	52	27252	43496	79673588
Throat irritation	27.62	12.79	50	27254	40896	79676188
Oxygen saturation decreased	27.58	12.79	102	27202	128945	79588139
Blood pressure increased	26.17	12.79	142	27162	211218	79505866
Intentional overdose	25.82	12.79	3	27301	105957	79611127
Hypertension	24.83	12.79	196	27108	330796	79386288
Oropharyngeal discomfort	24.42	12.79	20	27284	7146	79709938
Erythema	24.35	12.79	145	27159	223145	79493939
Heart rate irregular	23.45	12.79	41	27263	32638	79684446
Pruritus	21.04	12.79	217	27087	394431	79322653
Adrenocortical insufficiency acute	20.86	12.79	13	27291	3030	79714054
Autoimmune disorder	20.75	12.79	27	27277	16585	79700499
Mycobacterium chelonae infection	20.74	12.79	12	27292	2444	79714640
Hepatic function abnormal	20.21	12.79	63	27241	73044	79644040
Helicobacter infection	20.13	12.79	61	27243	69643	79647441
Secondary immunodeficiency	20.13	12.79	13	27291	3221	79713863
Myocardial infarction	20.12	12.79	20	27284	184109	79532975
Colitis ulcerative	19.22	12.79	39	27265	34703	79682381
Vascular rupture	19.11	12.79	10	27294	1675	79715409
Cytomegalovirus test positive	19.02	12.79	16	27288	5931	79711153
External ear cellulitis	18.90	12.79	6	27298	275	79716809
Adrenal insufficiency	18.22	12.79	34	27270	28453	79688631
Therapeutic product effect prolonged	18.15	12.79	7	27297	572	79716512
Weight increased	17.98	12.79	159	27145	277227	79439857
Heart rate increased	17.65	12.79	85	27219	120639	79596445
Blood iron decreased	17.61	12.79	24	27280	15410	79701674
Type 2 diabetes mellitus	17.46	12.79	51	27253	57071	79660013
Vein rupture	17.33	12.79	10	27294	2026	79715058
Duodenal ulcer perforation	17.33	12.79	56	27248	66155	79650929
Drug level above therapeutic	17.32	12.79	18	27286	8705	79708379
Chronic obstructive pulmonary disease	17.30	12.79	4	27300	85415	79631669
Therapeutic response shortened	17.10	12.79	24	27280	15839	79701245
Dislocation of vertebra	16.99	12.79	17	27287	7863	79709221
Facet joint syndrome	16.73	12.79	20	27284	11282	79705802
Pituitary tumour recurrent	16.70	12.79	5	27299	188	79716896
Acute kidney injury	16.57	12.79	107	27197	519297	79197787
Apocrine miliaria	16.54	12.79	3	27301	10	79717074
Intentional product misuse	16.45	12.79	6	27298	95159	79621925
Large intestine polyp	16.41	12.79	21	27283	12687	79704397
Drug ineffective	16.11	12.79	267	27037	1080646	78636438
Feeling hot	16.07	12.79	51	27253	59683	79657401
Traumatic shock	15.57	12.79	3	27301	15	79717069
Chills	15.54	12.79	101	27203	160133	79556951
Antithrombin III decreased	15.51	12.79	6	27298	494	79716590
X-ray abnormal	15.30	12.79	14	27290	5799	79711285
Psoriatic arthropathy	15.29	12.79	60	27244	77939	79639145
Cerebellar tumour	14.85	12.79	4	27300	102	79716982
Suicide attempt	14.72	12.79	5	27299	82927	79634157
Somnolence	14.72	12.79	38	27266	238943	79478141
Aspartate aminotransferase increased	14.44	12.79	89	27215	138552	79578532
Road traffic accident	14.33	12.79	40	27264	43624	79673460
Genital rash	14.28	12.79	7	27297	1021	79716063
Wheezing	14.17	12.79	78	27226	116586	79600498
Lower limb fracture	13.97	12.79	27	27277	23188	79693896
Phaeochromocytoma crisis	13.96	12.79	5	27299	332	79716752
Intestinal resection	13.90	12.79	11	27293	3746	79713338
White blood cell count decreased	13.82	12.79	111	27193	188177	79528907
Heart rate decreased	13.71	12.79	54	27250	70262	79646822
Cerebrovascular accident	13.64	12.79	20	27284	155272	79561812
Liver disorder	13.63	12.79	55	27249	72362	79644722
Tracheal inflammation	13.50	12.79	4	27300	145	79716939
Abdominal pain	13.28	12.79	197	27107	389372	79327712
Incorrect drug administration rate	13.23	12.79	11	27293	4015	79713069
Injection site pain	13.18	12.79	15	27289	129823	79587261
Ear pruritus	13.02	12.79	11	27293	4104	79712980
Rheumatoid arthritis	12.95	12.79	33	27271	208437	79508647
Pallor	12.79	12.79	42	27262	50020	79667064

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Source	Code	Description
FDA MoA	N0000175450	Corticosteroid Hormone Receptor Agonists
FDA EPC	N0000175576	Corticosteroid
MeSH PA	D000893	Anti-Inflammatory Agents
CHEBI has role	CHEBI:35472	anti-inflammatory drugs
CHEBI has role	CHEBI:49167	anti-asthmatic drugs
CHEBI has role	CHEBI:50857	anti-allergic drugs
CHEBI has role	CHEBI:75771	Mus musculus metabolites
CHEBI has role	CHEBI:77746	Homo sapiens metabolite
CHEBI has role	CHEBI:88188	allergenic drug

Drug Use | Suggest Off label Use Form| |View source of the data|

Disease	Relation	SNOMED_ID	DOID
Disorder of musculoskeletal system	indication	928000	DOID:17
Cerebral edema	indication	2032001
Berylliosis	indication	8247009	DOID:10322
Psoriasis	indication	9014002	DOID:8893
Ankylosing spondylitis	indication	9631008	DOID:7147
Rheumatic heart disease	indication	23685000
Atopic dermatitis	indication	24079001	DOID:3310
Inflammatory bowel disease	indication	24526004	DOID:0050589
Multiple sclerosis	indication	24700007	DOID:2377
Severe adrenal insufficiency	indication	24867002
Sarcoidosis	indication	31541009	DOID:11335
Idiopathic thrombocytopenic purpura	indication	32273002	DOID:8924
Psoriasis with arthropathy	indication	33339001
Crohn's disease	indication	34000006
Tendinitis	indication	34840004	DOID:971
Erythema multiforme	indication	36715001
Contact dermatitis	indication	40275004	DOID:2773
Angioedema	indication	41291007	DOID:1558
Humoral hypercalcemia of malignancy	indication	47709007
Articular gout	indication	48440001	DOID:13189
Edema of larynx	indication	51599000
Nephrotic syndrome	indication	52254009	DOID:1184
Systemic lupus erythematosus	indication	55464009	DOID:9074
Allergic rhinitis	indication	61582004
Löffler's syndrome	indication	64936001	DOID:9503
Pemphigus	indication	65172003	DOID:9182
Tenosynovitis	indication	67801009	DOID:970
Rheumatoid arthritis	indication	69896004	DOID:7148
Transfusion reaction due to serum protein reaction	indication	72284000
Acquired thrombocytopenia	indication	74576004	DOID:11126
Thyroiditis	indication	82119001	DOID:7166
Bursitis	indication	84017003	DOID:2965
Autoimmune disease	indication	85828009
Infection by larvae of Trichinella spiralis	indication	88264003
Congenital hypoplastic anemia	indication	88854002	DOID:1339
Acute lymphoid leukemia	indication	91857003	DOID:9952
Dermatitis herpetiformis	indication	111196000	DOID:8505
Hodgkin's disease	indication	118599009
Non-Hodgkin's lymphoma	indication	118601006
Mycosis fungoides	indication	118618005
Aspiration pneumonitis	indication	155597006
Asthma	indication	195967001	DOID:2841
Transplanted organ rejection	indication	213148006
Adrenogenital disorder	indication	267395000	DOID:0050811
Eruption of skin	indication	271807003	DOID:0050486
Disorder of eye	indication	371405004	DOID:5614
Primary adrenocortical insufficiency	indication	373662000
Adrenal cortical hypofunction	indication	386584007	DOID:10493
Erythroderma	indication	399992009
Autoimmune hemolytic anemia	indication	413603009	DOID:718
Synovitis	indication	416209007	DOID:2703
Post traumatic osteoarthritis	indication	699262001
Erythroblastic Anemia	indication
Diagnostic Test for Cushing's Syndrome	indication
Transfusion Reaction Urticaria	indication
Systemic Dermatomyositis	indication
Synovitis due to Osteoarthritis	indication
Respiratory distress syndrome in the newborn	off-label use	46775006
Neonatal Bronchopulmonary Dysplasia	off-label use
Mycosis	contraindication	3218000	DOID:1564
Ocular hypertension	contraindication	4210003	DOID:9282
Inactive tuberculosis	contraindication	11999007
Peptic ulcer	contraindication	13200003	DOID:750
Measles	contraindication	14189004	DOID:8622
Esophagitis	contraindication	16761005	DOID:11963
Mood swings	contraindication	18963009
Cirrhosis of liver	contraindication	19943007	DOID:5082
Glaucoma	contraindication	23986001	DOID:1686
Abscess of intestine	contraindication	24557004
Hypertensive disorder	contraindication	38341003	DOID:10763
Infectious disease	contraindication	40733004
Hypothyroidism	contraindication	40930008	DOID:1459
Hypokalemia	contraindication	43339004
Chronic heart failure	contraindication	48447003
Duodenal ulcer disease	contraindication	51868009	DOID:1724
Osteoporosis	contraindication	64859006	DOID:11476
Psychotic disorder	contraindication	69322001
Diabetes mellitus	contraindication	73211009	DOID:9351
Hypopituitarism	contraindication	74728003	DOID:9406
Hyperglycemia	contraindication	80394007	DOID:4195
Kidney disease	contraindication	90708001	DOID:557
Bilateral cataracts	contraindication	95722004
Eye infection	contraindication	128351009
Disorder of muscle	contraindication	129565002	DOID:423
Anastomosis of intestine	contraindication	235407009
Diverticulitis of gastrointestinal tract	contraindication	271366000
Varicella-zoster virus infection	contraindication	309465005
Viral eye infection	contraindication	312132001
Gastric ulcer	contraindication	397825006	DOID:10808
Exposure to varicella	contraindication	444453009

🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation level	Dissociation constant	Type (acidic/basic)
pKa1	4.23	acidic
pKa2	12.94	acidic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

Target	Class	Pharos	UniProt	Action	Type	Activity value (-log[M])	Mechanism action	Bioact source	MoA source
Glucocorticoid receptor	Nuclear hormone receptor	P04150	GCR_HUMAN	AGONIST				CHEMBL	CHEMBL
Glucocorticoid receptor	Transcription factor		GCR_MOUSE		Kd	6.72		CHEMBL

External reference:

ID	Source
D00978	KEGG_DRUG
4017945	VUID
N0000146295	NUI
4017941	VANDF
4017945	VANDF
CHEBI:31677	CHEBI
CHEBI:17650	CHEBI
CHEMBL3989663	ChEMBL_ID
CHEMBL977	ChEMBL_ID
CHEMBL1200495	ChEMBL_ID
DB14545	DRUGBANK_ID
C007133	MESH_SUPPLEMENTAL_RECORD_UI
83784-20-7	SECONDARY_CAS_RN
16623	PUBCHEM_CID
DB00741	DRUGBANK_ID
21651	RXNORM
20708	MMSL
2500	MMSL
41706	MMSL
4837	MMSL
4843	MMSL
73114	MMSL
d00254	MMSL
002147	NDDF
002152	NDDF
005251	NDDF
109066000	SNOMEDCT_US
16602005	SNOMEDCT_US
396458002	SNOMEDCT_US
C0056387	UMLSCUI
C0020268	UMLSCUI
38	INN_ID
5754	PUBCHEM_CID
D006854	MESH_DESCRIPTOR_UI
50LQB69S1Z	UNII

Pharmaceutical products:

Product	Category	Ingredients	NDC	Form	Quantity	Route	Marketing	Label
Solu-Cortef	HUMAN PRESCRIPTION DRUG LABEL	1	0009-0005	INJECTION, POWDER, FOR SOLUTION	1000 mg	INTRAMUSCULAR	NDA	22 sections
Solu-Cortef	HUMAN PRESCRIPTION DRUG LABEL	1	0009-0011	INJECTION, POWDER, FOR SOLUTION	100 mg	INTRAMUSCULAR	NDA	22 sections
Solu-Cortef	HUMAN PRESCRIPTION DRUG LABEL	1	0009-0013	INJECTION, POWDER, FOR SOLUTION	250 mg	INTRAMUSCULAR	NDA	22 sections
Solu-Cortef	HUMAN PRESCRIPTION DRUG LABEL	1	0009-0016	INJECTION, POWDER, FOR SOLUTION	500 mg	INTRAMUSCULAR	NDA	22 sections
Solu-Cortef	HUMAN PRESCRIPTION DRUG LABEL	1	0009-0825	INJECTION, POWDER, FOR SOLUTION	100 mg	INTRAMUSCULAR	NDA	22 sections
SOLU-CORTEF	HUMAN PRESCRIPTION DRUG LABEL	1	51662-1261	INJECTION, POWDER, FOR SOLUTION	100 mg	INTRAMUSCULAR	NDA	13 sections
SOLU-CORTEF	HUMAN PRESCRIPTION DRUG LABEL	1	51662-1261	INJECTION, POWDER, FOR SOLUTION	100 mg	INTRAMUSCULAR	NDA	13 sections
SOLU-CORTEF	HUMAN PRESCRIPTION DRUG LABEL	1	51662-1262	INJECTION, POWDER, FOR SOLUTION	250 mg	INTRAMUSCULAR	NDA	13 sections
SOLU-CORTEF	HUMAN PRESCRIPTION DRUG LABEL	1	51662-1262	INJECTION, POWDER, FOR SOLUTION	250 mg	INTRAMUSCULAR	NDA	13 sections
Solu-Cortef	HUMAN PRESCRIPTION DRUG LABEL	1	55154-3942	INJECTION, POWDER, FOR SOLUTION	100 mg	INTRAMUSCULAR	NDA	22 sections
Solu-Cortef	HUMAN PRESCRIPTION DRUG LABEL	1	55154-3942	INJECTION, POWDER, FOR SOLUTION	100 mg	INTRAMUSCULAR	NDA	22 sections
Solu-Cortef	HUMAN PRESCRIPTION DRUG LABEL	1	55154-3942	INJECTION, POWDER, FOR SOLUTION	100 mg	INTRAMUSCULAR	NDA	22 sections